Nitrite in Hypertrophic Cardiomyopathy (HCM) Study

  • Research type

    Research Study

  • Full title

    Mechanistic study of the effect of inorganic sodium nitrate on cardiac and skeletal muscle metabolic efficiency in patients with hypertrophic cardiomyopathy.

  • IRAS ID

    201323

  • Contact name

    Michael Frenneaux

  • Contact email

    m.frenneaux@uea.ac.uk

  • Sponsor organisation

    University of East Anglia

  • Clinicaltrials.gov Identifier

    NCT03251287

  • Duration of Study in the UK

    1 years, 10 months, 28 days

  • Research summary

    Nitrite has been shown to increase the efficiency in which skeletal muscle uses energy sources in the body. It is not known however, whether this also occurs in muscle in the heart. This study is designed to define whether nitrite improves energetic function of the heart in patients with hypertrophic cardiomyopathy (a heart condition characterised by energetic dysfunction). The study will comprise two visits that are two weeks apart. Participants will take inorganic sodium nitrate (to increase their nitrite levels) and a matching placebo tablet over the two visits: they will be randomised to either inorganic sodium nitrate or placebo on the first visit, with the other tablet to be taken on the second visit. Magnetic resonance imaging (MRI) and transthoracic echocardiography (TTE) will be used to assess heart function on both visits, so that function after taking the placebo can be compared to function after taking the inorganic sodium nitrate in the same patient.

  • REC name

    East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

  • REC reference

    16/EE/0161

  • Date of REC Opinion

    13 May 2016

  • REC opinion

    Further Information Favourable Opinion